These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 946965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW, Cruickshank N, Fowler EF.
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C, Stiffel C, Chalvet H, Biozzi G.
    C R Seances Acad Sci III; 1981 Oct 05; 293(4):225-8. PubMed ID: 6794870
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
    Mazurek C, Chalvet H, Stiffel C, Biozzi G.
    Int J Cancer; 1977 Oct 15; 20(4):532-4. PubMed ID: 334678
    [Abstract] [Full Text] [Related]

  • 9. Active experimental inhibition of cancer by corynebacterium parvum.
    Wrba H, Dutter A.
    Osterr Z Onkol; 1977 Oct 20; 4(2-3):60-1. PubMed ID: 579449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Oct 20; 32(4):413-9. PubMed ID: 6549500
    [Abstract] [Full Text] [Related]

  • 16. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Oct 20; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 17. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
    Fisher B, Wolmark N, Rubin H.
    J Natl Cancer Inst; 1976 Jul 20; 57(1):225-6. PubMed ID: 1003505
    [Abstract] [Full Text] [Related]

  • 18. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD, Sedlacek R, Wagner M, Orsi L, Silobrcic V, Rothman KJ.
    Cancer Res; 1976 Apr 20; 36(4):1305-14. PubMed ID: 1260756
    [Abstract] [Full Text] [Related]

  • 19. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV.
    J Natl Cancer Inst; 1976 May 20; 56(5):985-9. PubMed ID: 994209
    [Abstract] [Full Text] [Related]

  • 20. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG.
    Cancer Res; 1977 Apr 20; 37(4):1137-40. PubMed ID: 844041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.